by Sue Robbins | Oct 28, 2020 | Migraine
Fewer than one in three people with migraine took guideline-recommended prescription medication, data presented at the American Headache Society (AHS) annual scientific meeting showed. About 28% of survey respondents with mild to severe migraine-related...
by Sue Robbins | Oct 27, 2020 | Children's Pain, Miscellaneous
In a new report on pediatric pain in the British medical journal The Lancet, a commission of experts, including scientists, doctors, psychologists, parents and patients, challenged those who take care of children to end what they described as the common...
by Sue Robbins | Oct 26, 2020 | Migraine
The first dual-purpose, external trigeminal nerve stimulation device to treat and prevent acute migraine is now available over the counter to adults over age 18. The Food and Drug Administration has cleared Cefaly Dual (Cefaly Technology) which was...
by Sue Robbins | Oct 21, 2020 | Migraine
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, builds on the sensorial characteristics of migraine patients. The study, entitled “C-tactile touch perception in migraineurs – a case-control...
by Sue Robbins | Oct 20, 2020 | Migraine
A migraine is a neurovascular condition that is described as a debilitating and recurring headache. It is often accompanied by vomiting and some sensory sensitivities. It has been reported that 20% of the people who have migraines turn to prescription medication for...
